Antihyperalgesic and Anti-inflammatory Effects of Atorvastatin in Chronic Constriction Injury-Induced Neuropathic Pain in Rats
- 20 July 2013
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 36 (6) , 1468-1478
Abstract
Atorvastatin is a 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor used in treatment of hypercholesterolemia and prevention of coronary heart disease. The aim of this study is to investigate the antihyperalgesic and anti-inflammatory effects of atorvastatin (3, 10, and 30 mg/kg by oral gavages for 14 days) in chronic constriction injury (CCI) model of neuropathic pain in rats. CCI caused significant increase in tumor necrosis factor-α, interleukin 1 beta, prostaglandin E2, along with matrix metalloproteases (MMP-2) and nerve growth factor (NGF) levels in sciatic nerve and spinal cord concomitant with mechanical and thermal hyperalgesia, which were significantly reduced by oral administration of atorvastatin for 14 days as compared to CCI rats. Our study demonstrated that atorvastatin attenuates neuropathic pain through inhibition of cytokines, MMP-2, and NGF in sciatic nerve and spinal cord suggesting that atorvastatin could be an additional therapeutic strategy in management of neuropathic pain.Keywords
This publication has 81 references indexed in Scilit:
- Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injuryJournal of Neurosurgery, 2010
- Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulationProceedings of the National Academy of Sciences, 2009
- SIMVASTATIN ATTENUATES MICROGLIAL CELLS AND ASTROCYTE ACTIVATION AND DECREASES INTERLEUKIN-1B LEVEL AFTER TRAUMATIC BRAIN INJURYNeurosurgery, 2009
- Matrix metalloprotease regulation of neuropathic painTrends in Pharmacological Sciences, 2009
- Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic painNature Medicine, 2008
- Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injuryBMC Neurology, 2007
- The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-β1–42 in the rat hippocampus in vivoNeuropharmacology, 2007
- Matrix Metalloproteinase-2 Facilitates Wound Healing Events That Promote Functional Recovery after Spinal Cord InjuryThe Journal of Neuroscience, 2006
- Atorvastatin inhibits inflammatory hypernociceptionBritish Journal of Pharmacology, 2006
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002